nintedanib
nintedanib is listed in the FDA National Drug Code directory with 18 NDC codes, marketed under brand names including Ofev, Nintedanib, nintedanib. Available dosage form: capsule.
Drug details
- Generic Name
- nintedanib
- Brand Names
- Ofev, Nintedanib, nintedanib
- Application Number
- NDA205832
- Sponsor
- Boehringer Ingelheim Pharmaceuticals, Inc.
- NDC Codes
- 18
- Dosage Forms
- CAPSULE
- Routes
- ORAL
- Active Ingredients
- NINTEDANIB ESYLATE
Indications and Usage
1 INDICATIONS AND USAGE Nintedanib Capsules is a kinase inhibitor indicated in adults for: Treatment of idiopathic pulmonary fibrosis (IPF) ( 1.1 ) Treatment of chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype ( 1.2 ) 1.1 Idiopathic Pulmonary Fibrosis Nintedanib Capsules is indicated for the treatment of adults with idiopathic pulmonary fibrosis (IPF). 1.2 Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype Nintedanib Capsules is indicated for the treatment of adults with chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype [see Clinical Studies (14.2) ].